Probing the potential of rare earth elements in the development of new anticancer drugs: single molecule studies

• Josiane A. D. Batista,
• Rayane M. de Oliveira,
• Carlos H. M. Lima,
• Milton L. Lana Júnior,
• Virgílio C. dos Anjos,
• Maria J. V. Bell and
• Márcio S. Rocha

Beilstein J. Nanotechnol. 2025, 16, 187–194, doi:10.3762/bjnano.16.15

• condensation at high concentrations. These results suggest that rare earth elements can be used in the design of new drugs that have DNA as their target inside cells (e.g., chemotherapeutic drugs) or in the development of new carriers for drug delivery systems because of their ability to condense DNA

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

• decades of technological evolution, during which NCs have become indispensable components of drug delivery systems, known for their adaptability and efficiency [2]. The “family” of nanoparticles (NPs) includes a broad range of materials such as lipids, polymers, proteins, dextran, silica [3], and metals

• uptake and enabling the endosomal escape To improve the efficacy of NC-based drug delivery systems, it is crucial to develop strategies that reduce macrophage uptake and extend NC circulation time. This could be achieved by acting on NCs exploiting alternative administration routes or physicochemical

• potential of NCs by reducing macrophage uptake and extending circulation time. These strategies pave the way for more effective and targeted drug delivery systems. 5 Innovative therapeutic strategies using NCs Recent advancements in NC technologies have highlighted their remarkable potential in targeting

Mechanistic insights into endosomal escape by sodium oleate-modified liposomes

• Ebrahim Sadaqa,
• Satrialdi,
• Fransiska Kurniawan and
• Diky Mudhakir

Beilstein J. Nanotechnol. 2024, 15, 1667–1685, doi:10.3762/bjnano.15.131

• .15.131 Abstract Endosomal entrapment significantly limits the efficacy of drug delivery systems. This study investigates sodium oleate-modified liposomes (SO-Lipo) as an innovative strategy to enhance endosomal escape and improve cytosolic delivery in 4T1 triple-negative breast cancer cells. We aimed to

• ][32][33]. These findings establish SO as a promising endosomal escape enhancer, offering significant potential for improving the efficiency of liposomal drug delivery systems. By combining in vitro experimentation with in silico MD simulations, this study underscores the importance of integrated

• liposomal formulations with optimized endosomal escape capabilities, advancing the development of next-generation drug delivery systems. Conclusion This study provides a comprehensive analysis of the mechanisms through which SO-Lipo facilitate endosomal escape. Our findings demonstrate that SO-Lipo

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• targeting specificity. Biomimetic nanocarriers demonstrate significant advancements in drug delivery systems against cancer therapy, Alzheimer's disease, autoimmune diseases, and viral infections such as COVID-19. Here, we address the therapeutic applications of biomimetic nanocarriers and their promising

• main solutions that biomimetics addresses (Figure 2C). This approach has demonstrated that complex nanocarrier drug delivery systems need to exhibit compatible surfaces with target cells to enhance their functional capabilities [19]. Biomimetic Nanocarriers in Human Health The field of nanocarriers for

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

• Selin Akpinar Adscheid,
• Akif E. Türeli,
• Nazende Günday-Türeli and
• Marc Schneider

Beilstein J. Nanotechnol. 2024, 15, 1400–1414, doi:10.3762/bjnano.15.113

• drugs can be encapsulated into various drug delivery systems to enhance physicochemical characteristics and targeting success. Many preclinical data show that this strategy can effectively deliver biopharmaceuticals to the brain. Therefore, this review focuses on N2B delivery while giving examples of

• different drug delivery systems suitable for the applications. In addition, we emphasize the importance of the effective delivery of monoclonal antibodies and RNA and stress the recent literature tackling this challenge. While giving examples of nanotechnological approaches for the effective delivery of

• . While the systemic route of administration with the combination of drug delivery systems (DDSs) to cross the BBB has been promising, the efficiency is often not yet satisfactory [17]. Another noninvasive technique, nose-to-brain delivery or nasal-to-brain delivery (N2B delivery), in contrast, bypasses

Hymenoptera and biomimetic surfaces: insights and innovations

• Vinicius Marques Lopez,
• Carlo Polidori and
• Rhainer Guillermo Ferreira

Beilstein J. Nanotechnol. 2024, 15, 1333–1352, doi:10.3762/bjnano.15.107

• biodiversity, and assessing environmental impacts, providing researchers with valuable data while preserving natural habitats. Delivery systems: Strength and efficiency of the ovipositor also offer insights into creating advanced drug delivery systems [169]. These systems can deliver medications directly to

Synthesis, characterization and anticancer effect of doxorubicin-loaded dual stimuli-responsive smart nanopolymers

• Ömür Acet,
• Pavel Kirsanov,
• Burcu Önal Acet,
• Inessa Halets-Bui,
• Dzmitry Shcharbin,
• Şeyda Ceylan Cömert and
• Mehmet Odabaşı

Beilstein J. Nanotechnol. 2024, 15, 1189–1196, doi:10.3762/bjnano.15.96

• intended compartment, make thermo- and pH-sensitive polymers a crucial subset of smart polymers in drug delivery systems (DDSs). These responsive platforms must maintain stability at physiological pH levels [21]. Poly(N-isopropylacrylamide) (PNIPAM) stands out as one of the most common and most extensively

AI-assisted models to predict chemotherapy drugs modified with C₆₀ fullerene derivatives

• Jonathan-Siu-Loong Robles-Hernández,
• Dora Iliana Medina,
• Katerin Aguirre-Hurtado,
• Marlene Bosquez,
• Roberto Salcedo and
• Alan Miralrio

Beilstein J. Nanotechnol. 2024, 15, 1170–1188, doi:10.3762/bjnano.15.95

• treatments that release substances at specific sites of interest, reducing the required drug amount and side effects. Nanostructures to form these drug delivery systems can be divided into organic and inorganic [19][20], with the latter one being the less extensively studied. One option currently considered

Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis

• Damai Ria Setyawati,
• Fransiska Christydira Sekaringtyas,
• Riyona Desvy Pratiwi,
• A’liyatur Rosyidah,
• Rohimmahtunnissa Azhar,
• Nunik Gustini,
• Gita Syahputra,
• Idah Rosidah,
• Etik Mardliyati,
• Tarwadi and
• Sjaikhurrizal El Muttaqien

Beilstein J. Nanotechnol. 2024, 15, 1105–1116, doi:10.3762/bjnano.15.89

• played an important role in the enhancement of therapeutic outcomes compared to those of conventional therapy. At the same time, nanoparticle drug delivery systems offer a significant reduction in side effects of treatments by lowering the off-target biodistribution of the active pharmaceutical

• ]. The EPR effect has been a cornerstone for cancer nanomedicine development, and various types of nanocarrier drug delivery systems have been developed to take advantage of this passively targeted strategy. Moreover, active targeting strategies have been developed to further improve the drug

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications

• Shakhzodjon Uzokboev,
• Khojimukhammad Akhmadbekov,
• Ra’no Nuritdinova,
• Salah M. Tawfik and
• Yong-Ill Lee

Beilstein J. Nanotechnol. 2024, 15, 1077–1104, doi:10.3762/bjnano.15.88

• applications. Biodegradable and bioabsorbable polymers are an excellent choice for a variety of innovative drug delivery systems (DDSs). Biopolymers are also used in cutting-edge scientific applications such as gene expression, tissue engineering, smart drug delivery, and biosensors [11][19]. Modern medicine

• . Also, alginate-based nanoparticles possess excellent mechanical and electrical properties, overcoming the limitations typically associated with biomaterials in sensing applications [73]. Drug delivery applications Alginate-based nanoparticles for smart DDSs Drug delivery systems are one of the areas in

Electrospun nanofibers: building blocks for the repair of bone tissue

• Tuğrul Mert Serim,
• Gülin Amasya,
• Tuğba Eren-Böncü,
• Ceyda Tuba Şengel-Türk and
• Ayşe Nurten Özdemir

Beilstein J. Nanotechnol. 2024, 15, 941–953, doi:10.3762/bjnano.15.77

• , antibiotics, anticancer agents, proteins, DNA, RNA, and growth factors for tissue regeneration [6][7][8]. In addition, nanofibers as drug delivery systems provide rapid or delayed and controlled release of pharmaceuticals. Apart from being implantable drug delivery systems, nanofiber scaffolds can contribute

• used as drug delivery systems, which are composed of fibers from a few micrometers down to tens of nanometers in diameter [30]. Among the various scaffolds used for bone regeneration, polymeric nanofibrous scaffolds have attracted attention in recent years, especially regarding their structural

• delivery systems [1][2][3][4][5]. Because of the structural properties of nanofibers, which enable cell growth and proliferation, their use in tissue engineering, especially regarding bone tissue, is quite common [2]. Nanofiber scaffolds may carry active substances such as cells for tissue repair

Electrospun polysuccinimide scaffolds containing different salts as potential wound dressing material

• Veronika Pálos,
• Krisztina S. Nagy,
• Rita Pázmány,
• Krisztina Juriga-Tóth,
• Bálint Budavári,
• Judit Domokos,
• Dóra Szabó,
• Ákos Zsembery and
• Angela Jedlovszky-Hajdu

Beilstein J. Nanotechnol. 2024, 15, 781–796, doi:10.3762/bjnano.15.65

• )/hydroxyapatite in orthopedics [1][2]. Biocompatible polymers are widely used in biomedical fields, such as stents, drug delivery systems in cancer therapy, bone repair, dentistry, joint prostheses, and tissue engineering [2][3][4][5][6]. Polymers have several advantageous properties for these applications as

On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems

• Shan He,
• Julen Segura Abarrategi,
• Harbil Bediaga,
• Sonia Arrasate and
• Humberto González-Díaz

Beilstein J. Nanotechnol. 2024, 15, 535–555, doi:10.3762/bjnano.15.47

• drugs (NDDs) requires immediate attention. Nanoparticle (NP) systems are of increasing interest for transporting NDDs to the central nervous system. However, discovering effective nanoparticle neuronal disease drug delivery systems (N2D3Ss) is challenging because of the vast number of combinations of NP

• serve as valuable tools in the design of drug delivery systems for neurosciences. Keywords: artificial neural network (ANN); linear discriminant analysis (LDA); machine learning; nanoparticle; neurodegenerative diseases; Introduction Over time, there has been a significant shift in global dietary

• possible nanomedicine strategies for NDD transport to the central nervous system (CNS) [9][10]. For simplicity, we are going to call them nanoparticle neuronal diseases drug delivery systems (N2D3Ss). N2D3Ss have the ability to protect NDDs from chemical and enzymatic degradation, direct the active

Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

• Hsuan-Ang Tsai,
• Tsai-Miao Shih,
• Theodore Tsai,
• Jhe-Wei Hu,
• Yi-An Lai,
• Jui-Fu Hsiao and
• Guochuan Emil Tsai

Beilstein J. Nanotechnol. 2024, 15, 465–474, doi:10.3762/bjnano.15.42

• ) and enteric formulation. In this study, DCS nanocrystals were fabricated and investigated for novel drug delivery systems. Transdermal drug delivery is an administration route wherein the API is delivered across the skin for systemic distribution. The categories of TDD systems include reservoir

Nanomedicines against Chagas disease: a critical review

• Maria Jose Morilla,
• Kajal Ghosal and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30

• self-nanoemulsified drug delivery systems (SNEDDSs). SNEEDSs provide a pediatric liquid formulation of BNZ, which is only marketed as solid tablets. SNEDDSs are isotropic mixtures of oil, surfactants, and co-surfactants that form submicrometer-droplet emulsions under agitation in water or

Exploring the relationships between physiochemical properties of nanoparticles and cell damage to combat cancer growth using simple periodic table-based descriptors

• Joyita Roy and
• Kunal Roy

Beilstein J. Nanotechnol. 2024, 15, 297–309, doi:10.3762/bjnano.15.27

• = 0.54) showing the stability and predictive ability of the model. Utilization of the metal oxide cell damage knowledge for cancer treatment NPs have shown immense potential in treating various diseases owing to their small size and high surface-to-volume ratio, which makes them effective drug delivery

• systems. Metal NPs can lead to greater signal amplification, greater sensitivity, and higher detection. However, NPs with properties that generate ROS can increase cell damage. In cancer cells, rapid proliferation leads to an imbalance of oxygen, abnormal structure, and blood supply, making the tumor

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• drug delivery systems to formulate more effective cancer treatments, thereby addressing the current limitations encountered within this field of study. Functional nanostructures have been designed to mitigate potential harm to healthy tissue caused by these techniques [6]. Additionally, they facilitate

• anticancer drugs while mitigating the adverse effects of large dosage administration [6][7]. Additionally, it offers several advantages, such as controlled release, targeted drug delivery, and improved stability [8]. Moreover, nanoscale drug delivery systems hold great promise for specific cancer treatments

• photothermal therapy capabilities, the PDA shell mitigates nanomaterial toxicity while increasing biocompatibility. The strategic integration of PEGylation into tumor-targeted drug delivery systems significantly amplifies passive tumor targeting and retention through the enhanced permeability and retention

Berberine-loaded polylactic acid nanofiber scaffold as a drug delivery system: The relationship between chemical characteristics, drug-release behavior, and antibacterial efficiency

• Le Thi Le,
• Hue Thi Nguyen,
• Liem Thanh Nguyen,
• Huy Quang Tran and
• Thuy Thi Thu Nguyen

Beilstein J. Nanotechnol. 2024, 15, 71–82, doi:10.3762/bjnano.15.7

• polymer solution blended with additional components is applied under a high-voltage electrostatic field, generating a charged and stretched solution jet following nanofiber formation [8][9]. Drug delivery systems based on nanofiber scaffolds produced by electrospinning method have strongly attracted

• strongly affect the release behavior of the drug from nanofiber scaffolds [14][17][18][19]. Polylactic acid (PLA), a synthetic polymer that has been approved by the FDA for biomedical usage, is commonly used for drug delivery systems due to its biocompatibility and biodegradability [20]. Yuan et al. [17

• -based drug delivery systems for specific applications. Result and Discussion Morphology of PLA and BBR-loaded PLA nanofiber scaffolds In order to evaluate the distribution of BBR compositions in the electrospun PLA nanofibers, the morphology of BBR powder, BBR NPs, and electrospun nanofibers was

Influence of conductive carbon and MnCo₂O₄ on morphological and electrical properties of hydrogels for electrochemical energy conversion

• Sylwia Pawłowska,
• Karolina Cysewska,
• Yasamin Ziai,
• Jakub Karczewski,
• Piotr Jasiński and
• Sebastian Molin

Beilstein J. Nanotechnol. 2024, 15, 57–70, doi:10.3762/bjnano.15.6

• , such as environmental engineering [32], renewable energy [22][33][34][35], electronics [36][37][38], medical devices [39][40][41], and drug delivery systems [42][43][44][45]. They combine the properties of a hydrophilic matrix with conductive properties obtained thanks to the use of an appropriate

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• . Nanostructured systems with curcumin for the treatment of leishmaniasis Different nanostructured systems with curc intended for the treatment of leishmaniasis have been developed (Figure 3). The articles included in this work approach the following nanosystems: (i) self-nanoemulsifying drug-delivery systems

• (SNEDDSs), (ii) nanoliposomes, (iii) nanostructured lipid carriers, (iv) polymeric, and (v) metallic nanoparticles. Different performances of nanostructured systems containing curc are discussed in the section below. Self-nanoemulsifying drug-delivery systems The SNEDDSs are lipid-based drug-delivery

• limitations, improving their physicochemical and leishmanicidal properties [79][80]. In this context, curcumin-loaded SNEDDSs intended for the treatment of leishmaniasis were developed. Khan and collaborators developed curcumin-loaded self-emulsifying drug delivery systems (curc-SNEDDSs) for topical

Nanotechnological approaches in the treatment of schistosomiasis: an overview

• Lucas Carvalho,
• Michelle Sarcinelli and
• Beatriz Patrício

Beilstein J. Nanotechnol. 2024, 15, 13–25, doi:10.3762/bjnano.15.2

• nanocarriers to enhance drug delivery by ensuring that drugs are delivered in appropriate amounts to specific target areas and remains in the body for the necessary duration [12]. As a result, nanoparticles have been utilized mainly as drug delivery systems in various parasitic diseases, including

• S1 (Supporting Information File 1) summarizes all the articles found regarding the use of nanosystems and encapsulated drugs. In Figure 1, it is possible to observe that only 59% of the publications show effectiveness data solely in vivo. Also, most articles use nanoparticles as drug delivery systems

Elasticity, an often-overseen parameter in the development of nanoscale drug delivery systems

• Agnes-Valencia Weiss and
• Marc Schneider

Beilstein J. Nanotechnol. 2023, 14, 1149–1156, doi:10.3762/bjnano.14.95

• Agnes-Valencia Weiss Marc Schneider Department of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Saarland University, Campus C4 1, Saarbruecken, Germany 10.3762/bjnano.14.95 Abstract Nanoparticles have shown an enormous potential as drug delivery systems in the lab. However

• properties of drug carriers. Keywords: atomic force microscopy; drug delivery; elasticity; mechanical properties; nanomedicine; nanoparticles; stiffness measurement; tissue/body distribution; Introduction Drug delivery systems are developed with the aim to transport a given drug to the site of action

• encapsulated obtaining therapeutic relevant concentrations [1][2]. Nanoparticulate drug delivery systems have been researched for more than 35 years and show promising outcomes in the lab [3][4]. Unfortunately, even though nanoparticulate formulations often deliver positive results in vitro, the translation to

Curcumin-loaded albumin submicron particles with potential as a cancer therapy: an in vitro study

• Nittiya Suwannasom,
• Netsai Sriaksorn,
• Chutamas Thepmalee,
• Krissana Khoothiam,
• Ausanai Prapan,
• Hans Bäumler and
• Chonthida Thephinlap

Beilstein J. Nanotechnol. 2023, 14, 1127–1140, doi:10.3762/bjnano.14.93

• carrier of CUR through direct binding [22]. Kar et al. evaluated the affinity of HSA molecules to interact with CUR and reported that the binding constant was about 1.74 × 105 M−1, suggesting a strong interaction [23]. Therefore, albumin can be considered a useful carrier in drug delivery systems for

• . Also, it is seen that, despite the addition of CUR, a typical peanut-like structure was formed by the porous MnCO3 template, as previously found in our studies using the CCD technique [26][27][28][29]. There are strict size requirements for particles in drug delivery systems, typically around 100 nm

• [33]. While nanoparticles are generally more efficiently taken up by cells compared to microparticles, there are instances where the size of drug delivery systems can extend to 1000 nm. This was demonstrated by Bahrom et al., who showed that microparticles with sizes up to 1 µm can be taken up by

Nanoarchitectonics for advanced applications in energy, environment and biology: Method for everything in materials science

• Katsuhiko Ariga

Beilstein J. Nanotechnol. 2023, 14, 738–740, doi:10.3762/bjnano.14.60

• also discuss coordination-assembled myricetin nanoarchitectonics [32], nanoarchitectonics for membranes with enhanced gas separation capabilities [33], nanoarchitectonics of the cathode of Li–O2 batteries [34], nanoarchitectonics in moist-electric generation [35], nanoarchitectonics for drug delivery

• systems [36], nanoarchitectonics to entrap living cells [37], among other papers in which the concept of nanoarchitectonics has been applied to a variety of targets. Nanoarchitectonics integrates many existing disciplines and bridges nanotechnology and materials science. Due to the universality of the